Letters

Letters

Neurosurgery Joins Other Medical Groups in Sending A Letter to CMS Regarding the 2018 MIPS Quality Reporting Period

Last updated: April 29, 2025

Dear Administrator Verma: On behalf of the undersigned organizations, we urge the Centers for Medicare & Medicaid Services (CMS)to reduce the 2018 Merit-based Incentive Payment System (MIPS) quality measure reporting […]

• Quality Improvement and Patient Safety
• Reimbursement and Practice Management

Letters

Neurosurgery Sends Letter of Support to Reps. Meadows and Renacci for H.R. 4482, the “Opioid Abuse Deterrence, Research, and Recovery Act”

Last updated: April 29, 2025

SUBJECT: H.R. 4482, the Opioid Abuse Deterrence, Research, and Recovery Act Dear Representatives Meadows and Renacci: On behalf of the American Association of Neurological Surgeons (AANS) and Congress of NeurologicalSurgeons […]

• Drugs and Devices

Letters

Neurosurgery Leads Multispecialty Response to Washington State Draft Evidence Report On Surgery for Lumbar Radiculopathy 3.21.18

Last updated: April 29, 2025

SUBJECT: Washington State HTA Program Draft Evidence Report for Surgery for SymptomaticLumbar Radiculopathy Dear Mr. Morse: On behalf of the American Academy of Orthopaedic Surgeons (AAOS), American Association ofNeurological Surgeons […]

• Reimbursement and Practice Management

Letters

Neurosurgery Sends Letter to Senate Regarding H.R. 5311, CARA Act

Last updated: April 29, 2025

SUBJECT: H.R.5311, the CARA 2.0 Act of 201 Dear Representatives Blackburn, Ryan, MacArthur and Kuster: On behalf of the American Association of Neurological Surgeons (AANS) and Congress of NeurologicalSurgeons (CNS), […]

• Drugs and Devices

Letters

Neurosurgery Joins the Alliance in Sending a Letter to the House Ways and Means Committee in Response to the RFI Regarding the Opioid Crisis

Last updated: April 29, 2025

RE: Response to the Opioid Crisis Dear Chairman Brady, Ranking Member Neal, Chairman Roskam, and Ranking Member Levin: The Alliance of Specialty Medicine (the “Alliance”) represents more than 100,000 specialty […]

• Drugs and Devices

Letters

Neurosurgery Urges CMS to Implement Appropriate Medicare Part D Opioid Policy 3.5.18

Last updated: April 29, 2025

Subject: CMS-2017-0163, Advance Notice of Methodological Changes for Calendar Year(CY) 2019 for Medicare Advantage (MA) Capitation Rates, Part C and Part DPayment Policies and 2019 Draft Call Letter Dear Administrator […]

• Drugs and Devices

Letters

Neurosurgery Sends letter to Senate Regarding S. 2456, CARA Act

Last updated: April 29, 2025

SUBJECT: S. 2456, CARA 2.0 Act of 2018 Dear Senators Portman, Whitehouse, Capito, Klobuchar, Sullivan, Hassan, Cassidy and Cantwell: On behalf of the American Association of Neurological Surgeons (AANS) and […]

• Drugs and Devices

Letters

Neurosurgery Sends Letter to Sens. Hatch and Wyden Regarding Opioid Use

Last updated: April 30, 2025

Subject: AANS and CNS Feedback on Committee Questions Concerning PolicyRecommendations to Address Opioid and Substance Use Disorders. Dear Chairman Hatch and Ranking Member Wyden: The American Association of Neurological Surgeons […]

• Drugs and Devices

Letters

AANS Joins PCRC in Sending Letter to HHS Regarding Information Blocking by Electronic Health Record Vendors

Last updated: April 30, 2025

Re: Information Blocking by Electronic Health Record Vendors Dear Mr. Cannatti and Ms. Marchesini: The undersigned members of the Physician Clinical Registry Coalition (the “Coalition”) arewriting to express our ongoing […]

• Quality Improvement and Patient Safety

Letters

Neurosurgery Sends Letter to FDA Regarding Regulatory Reform

Last updated: April 30, 2025

Subject: Review of Existing Center for Devices and Radiological Health Regulatory andInformation Collection Requirements Dear Dr. Gottlieb, The American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons(CNS) appreciate […]

• Drugs and Devices